Brief: Relay Therapeutics Reports First Quarter 2023 Financial Results And Corporate Highlights
Relay Therapeutics Inc RLAY.O :
* RELAY THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND CORPORATE HIGHLIGHTS
* $937.8 MILLION IN CASH, CASH EQUIVALENTS AND INVESTMENTS
AT END
OF Q1 2023, EXPECTED TO FUND OPERATIONS INTO 2025
* QTRLY NET LOSS PER SHARE OF $0.78
* Q1 EARNINGS PER SHARE VIEW $-0.69 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6k3QQn
Further company coverage: RLAY.O
Recent news on Relay Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Moderna, Kontoor Brands, Ralph Lauren
U.S. STOCKS ON THE MOVE- Intuit, Deere, Advance Auto Parts
U.S. STOCKS ON THE MOVE-Keysight Technologies, Relay Therapeutics, Ralph Lauren
Relay Therapeutics gains after $275 mln equity raise
Brief: Relay Therapeutics Announces Pricing Of Public Offering Of Common Stock